Interview with Oliver Schacht, CEO of OpGen

Published on 18-11-2020 09:26:08


In this episode of Edison Talks, our director of research for North America, Maxim Jacobs, has an in-depth discussion with OpGen’s CEO, Oliver Schacht, who is seeking to revolutionize the diagnosis and treatment of bacterial infections. They cover OpGen’s various products including the Unyvero and Acuitas platforms as well as Ares Genetics.

00:44 Overview of OpGen
03:54 Discussion of the Unyvero and Acuitas platforms
12:04 The potential for Ares Genetics
22:05 New product roadmap
24:20 Summary of upcoming milestones